Share this page

 ENVERIC BIOSCIENCES — 2140526

Toolbar

Toolbar

Details

Third-party disclaimer

Share this page

No endorsement of any products or services is expressed or implied.

Third-party disclaimer

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Application number

2140526

Registration number

TMA1381552

Type(s)

Standard Characters

Category

Trademark

CIPO Status

REGISTERED

TM5 status

LIVE/REGISTRATION/Issued and Active
The trademark application has been registered with the Office.

Filed

2021-10-15

Registered

2026-01-30

Registration Expiry Date

2036-01-30

Registered Owner

Enveric Biosciences, Inc.
4851 Tamiami Trail N
Suite 200
Naples, FL 34103
UNITED STATES OF AMERICA

Agent

PIASETZKI NENNIGER KVAS LLP
10 King Street East, Suite 900
TORONTO
ONTARIO M5C1C3

Documents

View documents

Index headings

  • ENVERIC BIOSCIENCES
  • BIO SCIENCES

Goods (Nice class & Statement)

5
(1) Pharmaceutical products and preparations for the treatment of cancer, pain, mental health disorders, cancer related distress, anxiety, depression, post-traumatic stress disorder, neuropsychiatric disorders, and addiction disorders.

Services (Nice class & Statement)

42
(1) Pharmaceutical research services; medical research services; medical research laboratory services; research and development of new products for others; research and development services, for the development of a portfolio of psychoactive compounds and derivatives targeted for the treatment of medical conditions and disorders; research and development services, for the development of a portfolio of compounds and derivatives targeted for the treatment of cancer and the side effects of cancer; providing online nondownloadable computer software for data analytics, machine learning, knowledge management, and predictive analysis of biostatistical data and treatment data, in the field of medical research.

Action History

Actions
Action Action date Due date Comments
Filed 2021-10-15
Created 2021-10-15
Formalized 2021-10-15
Pre-Assessment Letter Sent 2022-05-16 Goods or Services Not Acceptable
Search Recorded 2025-01-15
Examiner's First Report 2025-01-15 2025-07-15
Approved 2025-09-04 APPROVED BY PROGRAM EX200M1
Approval Notice Sent 2025-09-04 APPROVED BY PROGRAM EX200M1
Advertised 2025-11-12 Vol.72 Issue 3707
Registration Pending 2026-01-30
Registered 2026-01-30 2036-01-30
Report a problem on this page
Date modified: